(Q40561627)
Statements
1 reference
An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings (English)
1 reference
Andrew J Palmer
1 reference
Lieven Annemans
1 reference
Stephane Roze
1 reference
Mark Lamotte
1 reference
Roger A Rodby
1 reference
Daniel J Cordonnier
1 reference
1 October 2003
1 reference
1 reference
18
1 reference
10
1 reference
2059-2066
1 reference
Identifiers
1 reference
1 reference